| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/09/1993 | US5185319 Administering a mixture of insulin and a 30hydroxypyrid-4-one |
| 02/09/1993 | US5185258 Subtilisin mutants |
| 02/09/1993 | US5185254 Gene family of tumor-associated antigens |
| 02/09/1993 | US5185253 Virus resistant plants |
| 02/09/1993 | US5185250 Human γ, δT cell antigen receptor polypeptides and nucleic acids |
| 02/09/1993 | US5185160 Platelet membrane microvesicles |
| 02/09/1993 | US5185148 Applying bioinsecticide |
| 02/09/1993 | US5185147 Protein is not one found in naturally occurring human immunodeficiency virus or other animal virus |
| 02/09/1993 | US5185146 Recombinant mva vaccinia virus |
| 02/09/1993 | CA2115159A1 Production of peptide amides |
| 02/09/1993 | CA2014033C Compositions and treatments for pneumonia in animals |
| 02/08/1993 | CA2075408A1 Human parathyroid hormone muteins and production thereof |
| 02/06/1993 | CA2075240A1 Chondromodulin-ii protein |
| 02/04/1993 | WO1993002358A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | WO1993002206A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | WO1993002205A1 Substance with anti-tumour action produced from macrophages |
| 02/04/1993 | WO1993002202A1 Compositions and methods for reproducing positive diagnostic indications |
| 02/04/1993 | WO1993002201A1 Nucleotide sequences and resistance proteins cycloheximide |
| 02/04/1993 | WO1993002200A1 Yeast strains with stable integration of heterologous genes |
| 02/04/1993 | WO1993002199A1 Novel type of gram positive replicon and construction of recombinant vectors containing same |
| 02/04/1993 | WO1993002193A1 cDNAS DERIVED FROM HEPATITIS C VIRUS |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002190A1 Production of antibodies |
| 02/04/1993 | WO1993002189A1 Transgenic animal models for alzheimer's disease |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002183A1 Serum-free tissue culture medium containing tissue inhibitor of metalloproteinase and method for cell growth |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002107A1 Immunoglobulin-combining artificial protein |
| 02/04/1993 | WO1993002106A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | WO1993002104A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | WO1993002103A1 Epitopes of the env protein of the hepatitis c virus |
| 02/04/1993 | WO1993002102A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 02/04/1993 | WO1993002099A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | WO1993002098A1 Isolation of charged particles from fluids |
| 02/04/1993 | WO1993002097A1 Protein v: a novel igg binding factor |
| 02/04/1993 | WO1993001833A1 Improved vaccine |
| 02/04/1993 | WO1993001828A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/04/1993 | WO1993001827A1 Osteoclast growth regulatory factor |
| 02/04/1993 | WO1993001820A2 Inhibition of non-cd4 mediated hiv infection |
| 02/04/1993 | WO1993001723A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 02/04/1993 | WO1992022332A3 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | DE4224050A1 Loesliche kit-liganden Soluble kit ligand |
| 02/04/1993 | DE4122599A1 Oberflaechen-expressionsvektor zum screenen von antikoerpern A roughness expression vector for antibody screening |
| 02/04/1993 | CA2113993A1 Protein v: a novel igg binding factor |
| 02/04/1993 | CA2113828A1 Osteoclast growth regulatory factor |
| 02/04/1993 | CA2113815A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | CA2113801A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | CA2113641A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | CA2113572A1 Improved vaccine |
| 02/04/1993 | CA2113358A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2113202A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | CA2113156A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/04/1993 | CA2111858A1 Production of antibodies |
| 02/03/1993 | EP0526397A1 Immunological detection method |
| 02/03/1993 | EP0526258A2 A87689 Compounds, their production and use as phospholipase-A2 inhibitors |
| 02/03/1993 | EP0525910A1 Non-A, non-B peptide |
| 02/03/1993 | EP0525889A1 Process for phosphate ester compounds of certain cyclohexapeptides |
| 02/03/1993 | EP0525838A2 Growth hormone releasing factor analogs |
| 02/03/1993 | EP0525828A2 Recombinant polypeptides and their uses, including assay for aids virus |
| 02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
| 02/03/1993 | EP0525508A2 Anti-palnogenic protein of ustilago maydis and use thereof |
| 02/03/1993 | EP0525502A1 Method for the preparation of virus-inactivated immunoglobuline solutions |
| 02/03/1993 | EP0525499A1 Amide derivatives of antibiotic A 40926 |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525115A1 Heat shock/stress response proteins and prognosis in cancer |
| 02/03/1993 | EP0525076A1 Recombinant bile salt activated lipases |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |
| 02/03/1993 | EP0386076B1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 02/03/1993 | EP0233915B1 Molecular farming |
| 02/03/1993 | CN1068501A A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 02/03/1993 | CA2075165A1 Non-a, non-b peptide |
| 02/02/1993 | WO1993003141A1 Ribozyme inhibition of bcr-abl gene expression |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183809 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
| 02/02/1993 | US5183805 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/02/1993 | US5183804 Anticarcinogenic agents |
| 02/02/1993 | US5183759 Recombinant Rhizobium bacteria inoculants |
| 02/02/1993 | US5183746 Formulation processes for pharmaceutical compositions of recombinant β- |
| 02/02/1993 | US5183745 Adenyl cyclase derivatives and their biological uses |
| 02/02/1993 | US5183734 Antibodies, diagnostic systems and methods for assaying SV40 HBxAg |
| 02/02/1993 | US5183660 Drugs having decreased antigenicity, delayed biological clearance and exhibit physiological activity over a long period |
| 02/02/1993 | CA2092571A1 Ribozyme inhibition of bcr-abl gene expression |
| 02/02/1993 | CA2075163A1 A87689 compounds |
| 02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
| 01/31/1993 | CA2074759A1 Process for phosphate ester compounds of certain cyclohexapeptides |
| 01/28/1993 | DE4224213A1 Hirudinanaloge und verfahren zu ihrer herstellung Hirudinanaloge and processes for their preparation |
| 01/28/1993 | DE4124758A1 Antitumorwirksame substanz aus humanen makrophagen Effective antitumor substance from human macrophages |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524832A2 Activator gene for macrolide biosynthesis |
| 01/27/1993 | EP0524803A2 Thromboplastin extract, reagent, and preparation thereof |
| 01/27/1993 | EP0524800A1 Adhesive formulations for binding proteins |
| 01/27/1993 | EP0524768A2 Ribotoxins, conjugates thereof ans pharmaceutical composition |
| 01/27/1993 | EP0524737A2 Protein s. polypeptides and anti-peptide antibodies that inhibit protein s binding TO C4b binding protein, diagnostic systems and therapeutic methods |
| 01/27/1993 | EP0524681A1 Process for the purification of serum albumin |
| 01/27/1993 | EP0524672A1 CCV vaccine |